- Home
- / Gracell
Gracell
Gracell Summary
Company Summary
- Overview
- Gracell Biotechnologies is a clinical-stage biotech company developing cell gene therapies for cancer. It focuses on leukemia, lymphoma, myeloma, and solid tumors.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2017
- HQ
- Suzhou, CN | view all locations
- Website
- https://www.gracellbio.com/
- Cybersecurity rating
Table of Contents
Key People
Kevin Yili Xie, Chief Financial Officer
Yili Kevin Xie, Chief Financial Officer
David Guowei Wang, Director
Operating MetricsView all
Preclinical Phase Products
1
Q3, 2020
Phase I Trials Products
4
Q3, 2020
LocationsView all
2 locations detected
Suzhou, Jiangsu Sheng HQ
China
Building 12, Block B, Phase II, Biobay Industrial Park, 218 Sangtian St., Suzhou Industrial Park
Shanghai Shi
China
12th floor, 926 Yishan Rd, Xuhui Qu
Gracell Financials
Summary Financials
- Net income (Q3, 2023)
- (¥67.6M)
- Cash (Q3, 2023)
- ¥1.7B
- EBIT (Q3, 2023)
- (¥119.4M)